Skip links

Drug Development Strategy

Biotech, MedTech, and small and specialty pharma companies depend on constant vigilance, careful attention to detail, and optimal use of limited resources to realize their products’ life-changing potential. Premier Consulting can help you ascend the challenging path from early discovery through IND application and post-approval life-cycle management.

Whether defining your strategy to achieve FDA buy-in, evaluating the overall appeal of your product concept, prioritizing product opportunities, or assessing a potential investment in an existing asset, we can help guide you throughout the process. Our product development experts, including therapeutic specialists, biostatisticians, and clinical operations professionals, can design a strategy that reduces risk and maximizes the likelihood of commercial success.

Services include:

Product concept evaluation: Starting with a target product profile, we assess the development risks and opportunities to clearly identify your idea’s potential.

U.S. market evaluation: Our experts evaluate your product’s potential by examining current and future competition, unmet needs, marketing requirements, market access considerations, and revenue opportunity, as well as conducting a SWOT analysis.

Business-case insights: We help develop the rationale for asset development or acquisition, including the proposed development outline, potential risks and roadblocks, and valuation.

Product development plan and pre-IND: Look to us for guidance when creating a detailed clinical and development plan, including time- and cost-to-market analysis, FDA feedback, necessary trials, and next steps.

Portfolio analysis: Premier Consulting experts provide a high-level product assessment, product concept analysis, and FDA-vetted development plan to clearly define your path.

To partner with Premier Consulting on your product development strategy, Contact Us.